tirzepatide heart health 𝐔𝐩𝐝𝐚𝐭𝐞 𝐢𝐧 𝐂𝐚𝐫𝐝𝐢𝐨𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐂𝐚𝐫𝐞 A large real-world study shows 𝐓𝐢𝐫𝐳𝐞𝐩𝐚𝐭𝐢𝐝𝐞 and 𝐒𝐞𝐦𝐚𝐠𝐥𝐮𝐭𝐢𝐝𝐞 provide 𝐜𝐨𝐦𝐩𝐚𝐫𝐚𝐛𝐥𝐞, 𝐬𝐭𝐫𝐨𝐧𝐠 𝐜𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐩𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 — lowering the risk Tirzepatide Reduces LV Mass and

The prevalence of obesity among adolescent girls (1219 years) in 2015/2016 was 20.9% (4) and 311% of these obese adolescent girls had PCOS (5, 6)

Some are also approved to help lower the risk of heart disease and cardiovascular events in people with diabetes or obesity

As well as supporting weight management, they reduce the risk of cardiovascular disease and can prevent the onset of type 2 diabetes

You can find more of her work in Mens Health , HealthCentral, Livestrong, Self, and others.

Thomas Ruiz, a board-certified OB/GYN and lead OB/GYN at MemorialCare Orange Coast Medical Center in Fountain Valley, CA, about this study

In David R